22157.jpg
Global Myelodysplastic Syndrome Treatment Drugs Market (2021 to 2029) - Featuring Bayer, Celgene and Incyte Among Others
June 17, 2021 07:58 ET | Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Myelodysplastic Syndrome (MDS) Treatment Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players,...
22157.jpg
China Lenalidomide Markets, 2016-2020 & 2021-2025: Sales Value was CNY297.4 Million in 2020 and the CAGR of Lenalidomide from 2016 to 2020 is 98.7%
May 11, 2021 05:23 ET | Research and Markets
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Lenalidomide Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Lenalidomide is an oral...
22157.jpg
Global CAR-T Pipeline Insight Report 2020: Overview, Landscape, Therapeutic Assessment, Current Treatment Scenario and Emerging Therapies
December 30, 2020 04:38 ET | Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "CAR-T - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. The "CAR-T - Pipeline Insight, 2020," report...
CC2.png
ChemioCare Announces Initiation of PETT Based (Permeation Enhanced Transdermal Technology) Lenalidomide Program
April 23, 2019 08:00 ET | ChemioCare
NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the Company is...